Literature DB >> 33330811

FDG-PET/CT images of COVID-19: a comprehensive review.

Ryogo Minamimoto1, Masatoshi Hotta1, Masahiro Ishikane2, Takeshi Inagaki3.   

Abstract

Following a lot of reports of coronavirus disease 2019 (COVID-19) CT images, the feature of FDG-PET/ CT imaging of COVID-19 was reported in several articles. Since FDG accumulates in activated inflammatory cells, FDG-PET/CT has huge potential for diagnosing and monitoring of inflammatory disease. However, FDG-PET/CT cannot be routinely used in an emergency setting and is not generally recommended as a first choice for diagnosis of infectious diseases. In this review, we demonstrate FDG-PET/CT imaging features of COVID-19, including our experience and current knowledge, and discuss the value of FDG-PET/CT in terms of estimating the pathologic mechanism. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; FDG; PET/CT; diagnosis

Year:  2020        PMID: 33330811      PMCID: PMC7731428          DOI: 10.35772/ghm.2020.01056

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  39 in total

1.  FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1).

Authors:  Emmanouil Panagiotidis; Demetrios Exarhos; Irene Housianakou; Apostolos Bournazos; Ioannis Datseris
Journal:  Eur Radiol       Date:  2010-02-26       Impact factor: 5.315

2.  (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.

Authors:  Matthew T Rondina; Uyen T Lam; Robert C Pendleton; Larry W Kraiss; Nathan Wanner; Guy A Zimmerman; John M Hoffman; Christopher Hanrahan; Kenneth Boucher; Paul E Christian; Regan I Butterfield; Kathryn A Morton
Journal:  Clin Nucl Med       Date:  2012-12       Impact factor: 7.794

3.  Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer.

Authors:  Christophe Dooms; Angela van Baardwijk; Eric Verbeken; Robert Jan van Suylen; Sigrid Stroobants; Dirk De Ruysscher; Johan Vansteenkiste
Journal:  J Thorac Oncol       Date:  2009-07       Impact factor: 15.609

4.  Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region.

Authors:  Domenico Albano; Francesco Bertagna; Mattia Bertoli; Giovanni Bosio; Silvia Lucchini; Federica Motta; Maria Beatrice Panarotto; Alessia Peli; Luca Camoni; Frank M Bengel; Raffaele Giubbini
Journal:  J Nucl Med       Date:  2020-04-01       Impact factor: 10.057

5.  CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV).

Authors:  Michael Chung; Adam Bernheim; Xueyan Mei; Ning Zhang; Mingqian Huang; Xianjun Zeng; Jiufa Cui; Wenjian Xu; Yang Yang; Zahi A Fayad; Adam Jacobi; Kunwei Li; Shaolin Li; Hong Shan
Journal:  Radiology       Date:  2020-02-04       Impact factor: 11.105

6.  [18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity.

Authors:  Lucia Zanoni; Cristina Mosconi; Veronica Cervati; Margherita Diegoli; Francesco Monteduro; Rita Golfieri; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-19       Impact factor: 9.236

7.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.

Authors:  Heshui Shi; Xiaoyu Han; Nanchuan Jiang; Yukun Cao; Osamah Alwalid; Jin Gu; Yanqing Fan; Chuansheng Zheng
Journal:  Lancet Infect Dis       Date:  2020-02-24       Impact factor: 25.071

8.  Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.

Authors:  Christel H Kamani; Mario Jreige; Martin Pappon; Arnaud Fischbacher; Olivier Borens; Pierre Monney; Marie Nicod Lalonde; Niklaus Schaefer; John O Prior
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-16       Impact factor: 9.236

9.  The potential added value of FDG PET/CT for COVID-19 pneumonia.

Authors:  Yan Deng; Lei Lei; Yue Chen; Wei Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-21       Impact factor: 9.236

Review 10.  COVID-19 pneumonia: A review of typical CT findings and differential diagnosis.

Authors:  C Hani; N H Trieu; I Saab; S Dangeard; S Bennani; G Chassagnon; M-P Revel
Journal:  Diagn Interv Imaging       Date:  2020-04-03       Impact factor: 4.026

View more
  12 in total

Review 1.  Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.

Authors:  Ryogo Minamimoto; Tomomichi Kiyomatsu
Journal:  Glob Health Med       Date:  2021-06-30

Review 2.  Positron emission tomography in the COVID-19 pandemic era.

Authors:  Chentao Jin; Xiaoyun Luo; Shufang Qian; Kai Zhang; Yuanxue Gao; Rui Zhou; Peili Cen; Zhoujiao Xu; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-19       Impact factor: 10.057

Review 3.  A comprehensive review of imaging findings in COVID-19 - status in early 2021.

Authors:  Ali Afshar-Oromieh; Helmut Prosch; Cornelia Schaefer-Prokop; Karl Peter Bohn; Ian Alberts; Clemens Mingels; Majda Thurnher; Paul Cumming; Kuangyu Shi; Alan Peters; Silvana Geleff; Xiaoli Lan; Feng Wang; Adrian Huber; Christoph Gräni; Johannes T Heverhagen; Axel Rominger; Matthias Fontanellaz; Heiko Schöder; Andreas Christe; Stavroula Mougiakakou; Lukas Ebner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-01       Impact factor: 9.236

4.  Primary lung invasive adenocarcinoma misdiagnosed as infectious pneumonia in 18F-FDG PET/CT:A case report.

Authors:  Yuping Han; Yongjun Luo
Journal:  Radiol Case Rep       Date:  2021-12-31

Review 5.  A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis.

Authors:  Adedayo Adeboye; Deya Alkhatib; Asra Butt; Neeraja Yedlapati; Nadish Garg
Journal:  Diagnostics (Basel)       Date:  2022-02-21

Review 6.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828

7.  Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates.

Authors:  Thibaut Naninck; Nidhal Kahlaoui; Julien Lemaitre; Pauline Maisonnasse; Antoine De Mori; Quentin Pascal; Vanessa Contreras; Romain Marlin; Francis Relouzat; Benoît Delache; Cécile Hérate; Yoann Aldon; Marit van Gils; Nerea Zabaleta; Raphaël Ho Tsong Fang; Nathalie Bosquet; Rogier W Sanders; Luk H Vandenberghe; Catherine Chapon; Roger Le Grand
Journal:  iScience       Date:  2022-03-17

8.  Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.

Authors:  Charalambos Vlachopoulos; Dimitrios Terentes-Printzios; Paraskevi Katsaounou; Eirini Solomou; Vasiliki Gardikioti; Dimitrios Exarchos; Dimitrios Economou; Georgia Christopoulou; Antonios-Dimosthenis Kalkinis; Pavlos Kafouris; Alexios Antonopoulos; Georgios Lazaros; Anastasia Kotanidou; Ioannis Datseris; Konstantinos Tsioufis; Constantinos Anagnostopoulos
Journal:  J Nucl Cardiol       Date:  2022-05-02       Impact factor: 3.872

9.  The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection.

Authors:  Abass Alavi; Thomas J Werner; Ali Gholamrezanezhad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04       Impact factor: 10.057

Review 10.  Imaging of Hematological Patients in the Era of COVID-19.

Authors:  Yael Eshet; Abraham Avigdor; Meirav Kedmi; Noam Tau
Journal:  Acta Haematol       Date:  2022-01-31       Impact factor: 3.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.